Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indira Guleria

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Biomedical Journal|October 31, 2014
Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetusSudipta Tripathi, Indira Guleria
Clinics in Laboratory Medicine|February 3, 2019
Biomarkers in Fetomaternal ToleranceSudipta Tripathi, Indira Guleria
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Maternal acceptance of the fetus: true human toleranceIndira Guleria, Mohamed H Sayegh
Methods in Molecular Medicine|March 4, 2006
Infection with Listeria monocytogenes as a probe for placental immunological functionEllen M Barber, Indira Guleria, Jeffrey W Pollard
Transplant Immunology|November 1, 2025
Pronase treatment enhances the sensitivity of B cell flow cytometry crossmatch: A single-center data analysisYan Li, Dean Sylvaria, Madeleine Billingsley, et al.
Annals of Surgery|October 1, 2010
The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcomeStefan G Tullius, Huong Tran, Indira Guleria, et al.
Plos One|April 22, 2015
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsSudipta Tripathi, Lola Chabtini, Pranal J Dakle, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2011
Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditisBechara Mfarrej, Mary Keir, Shirine Dada, et al.
Human Immunology|September 25, 2016
Antibodies against HLA-DP recognize broadly expressed epitopesDaimon P Simmons, Maria L Kafetzi, Isabelle Wood, et al.
Journal of Vascular Surgery|December 5, 2009
Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH studyMichael S Conte, Helen M Nugent, Peter Gaccione, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Biomedical Journal|October 31, 2014
Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetusSudipta Tripathi, Indira Guleria
Clinics in Laboratory Medicine|February 3, 2019
Biomarkers in Fetomaternal ToleranceSudipta Tripathi, Indira Guleria
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Maternal acceptance of the fetus: true human toleranceIndira Guleria, Mohamed H Sayegh
Methods in Molecular Medicine|March 4, 2006
Infection with Listeria monocytogenes as a probe for placental immunological functionEllen M Barber, Indira Guleria, Jeffrey W Pollard
Transplant Immunology|November 1, 2025
Pronase treatment enhances the sensitivity of B cell flow cytometry crossmatch: A single-center data analysisYan Li, Dean Sylvaria, Madeleine Billingsley, et al.
Annals of Surgery|October 1, 2010
The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcomeStefan G Tullius, Huong Tran, Indira Guleria, et al.
Plos One|April 22, 2015
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsSudipta Tripathi, Lola Chabtini, Pranal J Dakle, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2011
Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditisBechara Mfarrej, Mary Keir, Shirine Dada, et al.
Human Immunology|September 25, 2016
Antibodies against HLA-DP recognize broadly expressed epitopesDaimon P Simmons, Maria L Kafetzi, Isabelle Wood, et al.
Journal of Vascular Surgery|December 5, 2009
Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH studyMichael S Conte, Helen M Nugent, Peter Gaccione, et al.
Pageof 5